Clinical Trials Logo

Persian Gulf Syndrome clinical trials

View clinical trials related to Persian Gulf Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05992311 Not yet recruiting - Gulf War Syndrome Clinical Trials

Clinical Evaluation of Montelukast in Veterans With Gulf War Illness

(GWI)
Start date: April 1, 2024
Phase: Phase 1
Study type: Interventional

The study addresses the pre-clinical promise of Montelukast (MLK) for improving brain function in veterans with Gulf War Illness (GWI). MLK, a US Food and Drug administration (FDA)-approved drug for asthma, has shown efficacy in an animal model of GWI to improve cognitive and mood function through modulation of leukotriene signaling and suppression of neuroinflammation.